Edition:
United States

Achieve Life Sciences Inc (ACHV.OQ)

ACHV.OQ on NASDAQ Stock Exchange Capital Market

1.18USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,760
52-wk High
$10.18
52-wk Low
$1.15

Select another date:

Thu, Nov 9 2017

BRIEF-Achieve qtrly loss per share $0.90‍​

* Achieve Life Sciences Inc qtrly loss per share $0.90‍​ Source text for Eikon: Further company coverage:

BRIEF-Achieve Life Sciences entered into exclusive supply agreement with Sopharma AD

* Achieve Life Sciences -‍ co entered into exclusive supply agreement with Sopharma AD for manufacture of Cytisine API and finished tablets​

BRIEF-ACHIEVE LIFE SCIENCES COMMENCES ADVANCEMENT OF CYTISINE CLINICAL DEVELOPMENT PROGRAM

* ACHIEVE LIFE SCIENCES INC - ANNOUNCES COMMENCEMENT OF A MULTI-DOSE STUDY TO EVALUATE BOTH PK AND PD CHARACTERISTICS OF CYTISINE

BRIEF-Achieve announces share purchase agreement with Lincoln Park Capital Fund

* Achieve announces share purchase agreement with Lincoln Park Capital Fund LLC

BRIEF-Achieve Life Sciences ‍announces initiation of Cytisine clinical development program​

* Achieve Life Sciences Inc - ‍Announced initiation of Cytisine clinical development program​

BRIEF-Robert Schacter reports a 16.7 percent passive stake in Achieve Life Sciences as of Aug 1

* Robert Schacter reports a 16.7 percent passive stake in Achieve Life Sciences Inc as of August 1, 2017 - SEC filing‍​ Source text for Eikon: Further company coverage:

BRIEF-FDA accepts Achieve's IND for its smoking cessation drug

* Achieve announces FDA acceptance of the investigational new drug application (IND) for cytisine as a smoking cessation treatment

Select another date: